News

Filter

Current filters:

CopaxoneRegulation

1 to 9 of 11 results

Teva gets FDA approval of three-times-a-week Copaxone

Teva gets FDA approval of three-times-a-week Copaxone

29-01-2014

Israel’s Teva Pharmaceutical Industries says that the US Food and Drug Administration has approved…

CopaxoneNeurologicalNorth AmericaPharmaceuticalRegulationTeva Pharmaceutical IndustriesUSA

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

05-12-2013

Revealing an earlier agreement yesterday, Israel’s Teva Pharmaceutical Industries and Japan’s largest…

Asia-PacificCopaxoneGlatiramer AcetateLicensingNeurologicalPharmaceuticalRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

US FDA rejects Teva’s second try to block generic Copaxone; Shire sues Actavis over Intuniv

14-05-2010

The US Food and Drug Administration has rejected a second Citizen Petition from Israel-based Teva Pharmaceutical…

ActavisCopaxoneGenericsIntunivNeurologicalPatentsPharmaceuticalRegulationShireTeva Pharmaceutical Industries

1 to 9 of 11 results

Back to top